Granules

In a boost to Granules India Limited, the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets USP, 250 mg, 500 mg, 750 mg, and 1,000 mg. In an exchange filing on June 14, the Grnules confirmed the updates. Now, company has 58 ANDA approvals from US FDA (56 Final approvals and 2 tentative approvals.)